Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-07-21FDA Approved: GABAPENTIN — Original Application (TIME CAP LABORATORIES, INC)
FDA approved gabapentin as a generic drug under an Original Application submitted by Time Cap Laboratories, Inc. This approval enables marke…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures [Phase 3]
Results from a Phase 3 long-term safety study of lacosamide in adults with partial-onset seizures.
-
FDA label_change · 2011-07-15FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA page documents a supplemental application for TOPAMAX (topiramate) submitted by Janssen Pharmaceuticals, related to labeling changes…
-
FDA approval · 2011-07-14FDA Approved: GABAPENTIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for gabapentin submitted by Ascend Laboratories, LLC.
-
FDA approval · 2011-07-14FDA Approved: ACETAZOLAMIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved the original ANDA for Acetazolamide from Westminster Pharmaceuticals, making a generic version of the carbonic anhydrase inhibi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures [Phase 3]
This entry reports the long-term follow-up results from a Phase 3 study of Keppra XR (levetiracetam XR) for partial seizures. The trial comp…
-
FDA approval · 2011-07-07FDA Approved: TOPIRAMATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Topiramate by Aurobindo Pharma Limited under an ANDA.
-
CLINICAL_TRIALS research · 2011-06-29Clinical Trial Update: Does VNS Interact With the Serotonergic and Immune System in Children With Intractable Epilepsy? [Phase 2, Phase 3]
A clinical trial update examines whether vagus nerve stimulation (VNS) interacts with the serotonergic system and the immune system in child…
-
FDA approval · 2011-06-27FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for TOPAMAX (topiramate) filed by Janssen Pharmaceuticals, Inc., to update/expand the approved label…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Evaluation of Functional MRI and DTI (Imaging Techniques) in Children With Epilepsy and Focal Brain Lesions [NA]
A completed clinical trial evaluating functional MRI and diffusion tensor imaging in children with epilepsy and focal brain lesions. The stu…
-
FDA approval · 2011-06-24FDA Approved: TOPIRAMATE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for TOPIRAMATE (Cipla USA Inc.), authorizing changes to the product labeling under the ANDA.
-
FDA approval · 2011-06-24FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate by Zydus Lifesciences Limited.
-
FDA approval · 2011-06-24FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited, updating the approved generic Topiramate product. Th…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: COPE Intervention for Parents of Children With Epilepsy [Phase 1]
Phase 1 trial of the COPE Intervention for Parents of Children With Epilepsy conducted by Boston Children's Hospital has completed.
-
FDA approval · 2011-06-21FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal XR (lamotrigine) from GlaxoSmithKline LLC. The approval updates the labeling/indication…
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: Clinical Study With Lyrica In Patients Suffering From Epilepsy
Clinical study update for Lyrica in epilepsy patients; trial completed with results posted in 2011.
-
FDA approval · 2011-06-15FDA Approved: ZARONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Zarontin (ethosuximide) from Parke-Davis (Pfizer), indicating approval of changes to its lab…
-
FDA approval · 2011-06-15FDA Approved: CELONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Celontin (methsuximide) submitted by Parke-Davis Div of Pfizer Inc. The action pertains to a…
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Study of Algorithm for Epilepsy Alert Device
Completed study evaluating an algorithm for an epilepsy alert device for motor seizures.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy [Phase 4]
A Phase 4 clinical trial evaluating dosing, effectiveness, and safety of topiramate for epilepsy.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment [Phase 3]
Phase 3 clinical trial comparing the safety and effectiveness of topiramate versus phenytoin in patients with new-onset epilepsy requiring r…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy [Phase 3]
This Phase 3 study assessed the effectiveness and safety of topiramate in children with epilepsy and has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy. [Phase 2]
Phase 2 clinical trial assessing the efficacy and safety of Topiramate in patients with epilepsy, including partial seizures; the study has …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures [Phase 3]
Phase 3 trial evaluating topiramate as add-on therapy for primary generalized tonic-clonic seizures in epilepsy; study completed.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures [Phase 2]
A Phase 2 study evaluating the efficacy and safety of adding topiramate to existing therapy in patients with difficult-to-treat partial-onse…